This review looks at risk factor exposure, disease course, biomarkers, socioeconomic status and access to healthcare between White and Black patients with MS. It also discusses response to disease modifying therapy and calls for more inclusion of Black patients with MS in research, in order to better understand these differences and improve health equity.
Click here to access this resource.
- Authors: Cipriani and Klein
- Publication: Current Neurology and Neuroscience Reports
- Year: 2019